Literature DB >> 30598391

Appropriate treatment planning method for field joint dose in total body irradiation using helical tomotherapy.

Keisuke Usui1, Akira Isobe2, Naoya Hara2, Naoto Shikama3, Keisuke Sasai3, Koichi Ogawa4.   

Abstract

Total body irradiation (TBI) using helical tomotherapy (HT) has advantages over the standard linear accelerator-based approach to the conditioning regimen for hematopoietic cell transplantation. However, the radiation field has to be divided into two independent irradiation plans to deliver a homogeneous dose to the whole body. A clinical target volume near the skin increases the skin surface dose; therefore, high- or low-dose regions arise depending on the set-up position accuracy because the two radiation fields are somewhat overlapped or separated. We aimed to determine an adequate treatment planning method robust to the set-up accuracy for the field joint dose distribution using HT-TBI. We calculated treatment plans reducing target volumes at the interface between the upper and lower body irradiations and evaluated these joint dose distributions via simulation and experimental studies. Target volumes used for the optimization calculation were reduced by 0, 0.5, 1.0, 2.0, 2.5, and 3.0 cm from the boundary surface on the upper and lower sides. Combined dose distributions with set-up error simulated by modifying coordinate positions were investigated to find the optimal planning method. In the ideal set-up position, the target volume without a gap area caused field junctional doses of up to approximately 200%; therefore, target volumes reduced by 2.0-3.0 cm could suppress the maximum dose to within 150%. However, with set-up error, high-dose areas exceeding 150% and low-dose areas below 100% were found with 2.0 and 3.0 cm target volume reduction. Using the dynamic jaw (DJ) system, dose deviations caused by set-up error reached approximately 20%, which is not suitable for HT-TBI. Moreover, these dose distributions can be easily adjusted when combined with the intensity modulation technique for field boundary regions. The results of a simulation and experimental study using a film dosimetry were almost identical, which indicated that reducing the target volume at the field boundary surface by 2.5 cm produces the most appropriate target definition.
Copyright © 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Keywords:  Optimization; Set-up error; TBI; Tomotherapy; Treatment planning

Mesh:

Year:  2018        PMID: 30598391     DOI: 10.1016/j.meddos.2018.12.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  5 in total

1.  The effects of rotational setup errors in total body irradiation using helical tomotherapy.

Authors:  Akira Isobe; Keisuke Usui; Naoya Hara; Keisuke Sasai
Journal:  J Appl Clin Med Phys       Date:  2021-05-24       Impact factor: 2.102

2.  Feasibility of hybrid TomoHelical- and TomoDirect-based volumetric gradient matching technique for total body irradiation.

Authors:  Chae-Seon Hong; Min-Joo Kim; Jihun Kim; Kyung Hwan Chang; Kwangwoo Park; Dong Wook Kim; Min Cheol Han; Hong In Yoon; Jin Sung Kim; Ho Lee
Journal:  Radiat Oncol       Date:  2019-12-19       Impact factor: 3.481

3.  Technical note: factors affecting dose distribution in the overlap region of two-segment total body irradiation by helical tomotherapy.

Authors:  HaiYang Wang; JunQi Liu; YiFei Pi; Qi Liu; Yang Mi; XiangXiang Yang; YueXin Guo; RuiTai Fan
Journal:  Radiat Oncol       Date:  2020-11-07       Impact factor: 3.481

4.  Comparison of Absolute Dose Achievable Between Helical Tomotherapy and RapidArc in Total Dura Mater Irradiation for Child Cancer.

Authors:  Wenzhao Sun; Jun Zhang; Yixuan Wang; Meining Chen; Jianli Wang; Li Chen; Lixia Lu; Xiaowu Deng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  Optimized Conformal Total Body Irradiation methods with Helical TomoTherapy and Elekta VMAT: Implementation, Imaging, Planning and Dose Delivery for Pediatric Patients.

Authors:  Anna Anzorovna Loginova; Diana Anatolievna Tovmasian; Anastasiya Olegovna Lisovskaya; Daria Alexeevna Kobyzeva; Michael Alexandrovich Maschan; Alexander Petrovich Chernyaev; Oleg Borisovich Egorov; Alexey Vladimirovich Nechesnyuk
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.